| Mrs Kasie Yvonne Birdwell, MS CCC SLP | |
|
17706 I30, Ste 3, Benton, AR 72015 | |
| (501) 315-4414 | |
| (501) 315-3467 |
| Full Name | Mrs Kasie Yvonne Birdwell |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 17706 I30, Benton, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194784967 | NPI | - | NPPES |
| 5Y067 | Other | AR | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP2201 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kasie Yvonne Birdwell, MS CCC SLP 17706 I30, Ste 3, Benton, AR 72015 Ph: (501) 315-4414 | Mrs Kasie Yvonne Birdwell, MS CCC SLP 17706 I30, Ste 3, Benton, AR 72015 Ph: (501) 315-4414 |
News Archive
Amerigroup Corporation today announced that net income for the first quarter of 2011 was $70.5 million, or $1.37 per diluted share, versus net income of $42.2 million, or $0.82 per diluted share, for the first quarter of 2010. Total revenues for the first quarter of 2011 increased 12.3% to $1.54 billion compared with $1.37 billion in the first quarter of 2010. Sequentially, total revenues increased 2.5% from the fourth quarter of 2010.
Cardiovascular disease from atherosclerosis is one of the most common causes of death worldwide. Inflammation plays a crucial role in atherosclerosis and cholesterol crystals are considered to be early triggers in the development of the disease.
The researchers from the University of Cambridge, Cambridge United Kingdom have published their findings in a study titled, "Rapid implementation of SARS-CoV-2 sequencing to investigate cases of healthcare-associated COVID-19: a prospective genomic surveillance study," in the latest issue of The Lancet Infectious Diseases.
AbbVie, a research-based global biopharmaceutical company, today announced it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for venetoclax in combination with a hypomethylating agent or in combination with low-dose cytarabine for the treatment of newly diagnosed patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.
Today, Medivir AB, a research-based specialty pharmaceutical company focused on infectious diseases, is publishing its Interim Report for the period 1 January - 31 December and its operational report for the fourth quarter of 2011.
› Verified 1 days ago
Arkansas Therapy Outreach, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3851 Legacy Village Dr, Benton, AR 72015 Phone: 501-350-7572 Fax: 501-776-4059 | |
Cassandra Powell, M.S.CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Park Dr, Benton, AR 72015 Phone: 501-315-0136 | |
Taylor Gibbs Crosby, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17706 Interstate 30 N Ste 3, Benton, AR 72019 Phone: 501-315-4414 | |
Ryan Russell, MSSLP.CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6701 Highway 67, Benton, AR 72015 Phone: 501-860-0777 | |
Rebekah Anne Kennedy, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17706 Interstate 30 N Ste 3, Benton, AR 72019 Phone: 501-315-4414 | |
Jessica Faye Huffty, MS, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3214 Winchester, Benton, AR 72015 Phone: 501-315-4414 Fax: 501-315-3467 | |
Mckenna Lynn Zeringue, M.S. CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17706 I 30, Benton, AR 72019 Phone: 501-315-4414 |